$3.75
-0.10[-2.60%]
At close: Mar 28
$3.75
0[0.00%]
After Hours: 6:57PM EDT
Xenetic Biosciences
(NASDAQ:XBIO)Xenetic Biosciences Stock (NASDAQ:XBIO), Analyst Ratings, Price Targets, Predictions
Xenetic Biosciences Inc has a consensus price target of $0, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 16, 2023, April 11, 2023, and May 2, 2022. With an average price target of $2.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied -28.89% downside for Xenetic Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Xenetic Biosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/16/2023 | XBIO | Buy Now | Xenetic Biosciences | $3.75 | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2023 | XBIO | Buy Now | Xenetic Biosciences | $3.75 | 6.67% | HC Wainwright & Co. | Joseph Pantginis | → $40 | Reiterates | → Buy | Get Alert |
| 05/02/2022 | XBIO | Buy Now | Xenetic Biosciences | $3.75 | 6.67% | HC Wainwright & Co. | Joseph Pantginis | $50 → $40 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Xenetic Biosciences (XBIO)?
The latest price target for Xenetic Biosciences (NASDAQ: XBIO) was reported by HC Wainwright & Co. on May 16, 2023. The analyst firm set a price target for $0.00 expecting XBIO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xenetic Biosciences (XBIO)?
The latest analyst rating for Xenetic Biosciences (NASDAQ: XBIO) was provided by HC Wainwright & Co., and Xenetic Biosciences downgraded their neutral rating.
When was the last upgrade for Xenetic Biosciences (XBIO)?
There is no last upgrade for Xenetic Biosciences.
When was the last downgrade for Xenetic Biosciences (XBIO)?
The last downgrade for Xenetic Biosciences Inc happened on May 16, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Xenetic Biosciences Inc.
When is the next analyst rating going to be posted or updated for Xenetic Biosciences (XBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xenetic Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xenetic Biosciences was filed on May 16, 2023 so you should expect the next rating to be made available sometime around May 16, 2024.
Is the Analyst Rating Xenetic Biosciences (XBIO) correct?
While ratings are subjective and will change, the latest Xenetic Biosciences (XBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Xenetic Biosciences (XBIO) is trading at is $3.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.